Status:
COMPLETED
Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)
Lead Sponsor:
University of Florida
Conditions:
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Eligibility:
All Genders
10-18 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if Atorvastatin can improve blood vessel stiffness and blood vessel function in children 10-18 years old with Type 1 and Type 2 diabetes. Subjects will receiv...
Eligibility Criteria
Inclusion
- Type 1 Diabetes Mellitus (T1DM) or Type 2 Diabetes Mellitus (T2DM) for more than 1 year
- Age 10-18 years.
Exclusion
- Cardiovascular disease (CVD)
- Liver disease
- Pregnancy
- Use of cholesterol or triglyceride lowering drugs
- Perceived inability to comply with the study protocol
- Endocrinopathy other than diabetes
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
End Date :
April 1 2007
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00130481
Start Date
April 1 2005
End Date
April 1 2007
Last Update
March 7 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32610